<code id='BBE2391867'></code><style id='BBE2391867'></style>
    • <acronym id='BBE2391867'></acronym>
      <center id='BBE2391867'><center id='BBE2391867'><tfoot id='BBE2391867'></tfoot></center><abbr id='BBE2391867'><dir id='BBE2391867'><tfoot id='BBE2391867'></tfoot><noframes id='BBE2391867'>

    • <optgroup id='BBE2391867'><strike id='BBE2391867'><sup id='BBE2391867'></sup></strike><code id='BBE2391867'></code></optgroup>
        1. <b id='BBE2391867'><label id='BBE2391867'><select id='BBE2391867'><dt id='BBE2391867'><span id='BBE2391867'></span></dt></select></label></b><u id='BBE2391867'></u>
          <i id='BBE2391867'><strike id='BBE2391867'><tt id='BBE2391867'><pre id='BBE2391867'></pre></tt></strike></i>

          Home / hotspot / focus

          focus


          focus

          author:explore    Page View:5
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In